Apitherapy in Post-Ischemic Brain Neurodegeneration of Alzheimer's Disease Proteinopathy: Focus on Honey and Its Flavonoids and Phenolic Acids
- PMID: 37570596
- PMCID: PMC10420307
- DOI: 10.3390/molecules28155624
Apitherapy in Post-Ischemic Brain Neurodegeneration of Alzheimer's Disease Proteinopathy: Focus on Honey and Its Flavonoids and Phenolic Acids
Abstract
Neurodegeneration of the brain after ischemia is a major cause of severe, long-term disability, dementia, and mortality, which is a global problem. These phenomena are attributed to excitotoxicity, changes in the blood-brain barrier, neuroinflammation, oxidative stress, vasoconstriction, cerebral amyloid angiopathy, amyloid plaques, neurofibrillary tangles, and ultimately neuronal death. In addition, genetic factors such as post-ischemic changes in genetic programming in the expression of amyloid protein precursor, β-secretase, presenilin-1 and -2, and tau protein play an important role in the irreversible progression of post-ischemic neurodegeneration. Since current treatment is aimed at preventing symptoms such as dementia and disability, the search for causative therapy that would be helpful in preventing and treating post-ischemic neurodegeneration of Alzheimer's disease proteinopathy is ongoing. Numerous studies have shown that the high contents of flavonoids and phenolic acids in honey have antioxidant, anti-inflammatory, anti-apoptotic, anti-amyloid, anti-tau protein, anticholinesterase, serotonergic, and AMPAK activities, influencing signal transmission and neuroprotective effects. Notably, in many preclinical studies, flavonoids and phenolic acids, the main components of honey, were also effective when administered after ischemia, suggesting their possible use in promoting recovery in stroke patients. This review provides new insight into honey's potential to prevent brain ischemia as well as to ameliorate damage in advanced post-ischemic brain neurodegeneration.
Keywords: Alzheimer’s disease proteinopathy; amyloid; apitherapy; apoptosis; brain ischemia; excitotoxicity; honey; neurodegeneration; neuroinflammation; tau protein.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Ischemia-Reperfusion Programming of Alzheimer's Disease-Related Genes-A New Perspective on Brain Neurodegeneration after Cardiac Arrest.Int J Mol Sci. 2024 Jan 20;25(2):1291. doi: 10.3390/ijms25021291. Int J Mol Sci. 2024. PMID: 38279289 Free PMC article.
-
Post-Ischemic Brain Neurodegeneration in the Form of Alzheimer's Disease Proteinopathy: Possible Therapeutic Role of Curcumin.Nutrients. 2022 Jan 7;14(2):248. doi: 10.3390/nu14020248. Nutrients. 2022. PMID: 35057429 Free PMC article. Review.
-
Post-Ischemic Neurodegeneration of the Hippocampus Resembling Alzheimer's Disease Proteinopathy.Int J Mol Sci. 2021 Dec 28;23(1):306. doi: 10.3390/ijms23010306. Int J Mol Sci. 2021. PMID: 35008731 Free PMC article. Review.
-
The Many Faces of Post-Ischemic Tau Protein in Brain Neurodegeneration of the Alzheimer's Disease Type.Cells. 2021 Aug 27;10(9):2213. doi: 10.3390/cells10092213. Cells. 2021. PMID: 34571862 Free PMC article. Review.
-
Participation of Amyloid and Tau Protein in Post-Ischemic Neurodegeneration of the Hippocampus of a Nature Identical to Alzheimer's Disease.Int J Mol Sci. 2021 Feb 28;22(5):2460. doi: 10.3390/ijms22052460. Int J Mol Sci. 2021. PMID: 33671097 Free PMC article. Review.
Cited by
-
Emerging Role of Plant-Based Bioactive Compounds as Therapeutics in Parkinson's Disease.Molecules. 2023 Nov 14;28(22):7588. doi: 10.3390/molecules28227588. Molecules. 2023. PMID: 38005310 Free PMC article. Review.
-
The Dual Role of Autophagy in Postischemic Brain Neurodegeneration of Alzheimer's Disease Proteinopathy.Int J Mol Sci. 2023 Sep 7;24(18):13793. doi: 10.3390/ijms241813793. Int J Mol Sci. 2023. PMID: 37762096 Free PMC article. Review.
References
-
- Mandzia J., Cipriano L.E., Kapral M.K., Fang J., Hachinski V., Sposato L.A. Intravenous thrombolysis after first-ever ischemic stroke and reduced incident dementia rate. Stroke. 2022;53:1170–1177. - PubMed
-
- Feigin V.L., Stark B.A., Johnson C.O., Roth G.A., Bisignano C., Abady G.G., Abbasifard M., Abbasi-Kangevari M., Abd-Allah F., Abedi V., et al. Global, regional, and national burden of stroke and its risk factors, 1990–2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 2021;20:795–820. doi: 10.1016/S1474-4422(21)00252-0. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical